Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright Notice

Pfizer SWOT

Pfizer—a ***** Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one ***** the ***** most profitable companies. It has a well-respected n*****me known all over the world and commands some of ***** top research, advertising, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even the American Heart Association recommends ***** use of ***** such as Lipitor to reduce cholesterol when diet ***** exercise fail to reduce this common health problem. High cholesterol as a common health problem is only likely ***** *****cre*****e with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied to Lipitor" which is dangerous for the company in ***** future as Lipitor's patent will expire in several years, which means it will face competition from cheaper, generic drugs (Berenson, 2007). Pfizer's reputation has also been ta*****ted by its association with Celebrex, a p*****in medication that has been tied to increased risk of heart **********, in comparison to over-the-counter painkillers. The prominence ***** the Pfizer advertising campaign for ***** drug, followed by ***** rapid f***** *****rom grace undoubtedly damaged the company's trusted name.

Pfizer ***** manufactures Zoloft, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing ***** suicidal thoughts in this population. The company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' drugs like Viagra have come under *****creased media scrutiny and *****d as examples of the over-prescription of medication in the American *****care system in general. Healthcare in America is grow*****g more and ***** expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay for drugs.

*****, Exubera, "the first and so far only commercially available inhaled-insulin diabetes treatment," is on ***** verge of turning in***** an "expensive failure" as Pfizer "***** been dogged by questions about its safety, cost ********** convenience" (Berenson, 2007).

*****

According to the Pfizer press release section of its website, discom*****t associated with fibromyaglia, a ***** chronic pain condition, has been s*****n ***** be significantly reduced ***** a new drug developed by ***** called Lyrica, "according to study results presented ***** at the American Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has also developed a new AIDS drug called Maraviroc, which is likely to considerably improve and extend the life ***** AIDS patients who take the drug, according to researchers at ***** University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

***** Merck and Schering-Plough, ***** of Pfizer's greatest rivals, plan to combine forces ***** develop a medicine to rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit the market when Lipitor's patent expires in a few *****" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF RESEARCH PAPER PREVIEW]

Download full paper (and others like it)    |    Order a one-of-a-kind, custom paper

© 2001–2017   |   Book Report on Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Dissertations Sample